SYNLOGIC, INC. operates in the Pharmaceutical Preparations industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - | - |
| Net Income | -3.2M | -23M | -61M | -66M | -61M | -59M |
| EPS | $-0.26 | $-1.92 | $-9.42 | $-13.83 | $-1.09 | $-1.65 |
| Free Cash Flow | 0 | -32M | -52M | -58M | -53M | -40M |
| ROIC | -21.2% | -253.7% | -133.0% | -80.1% | -41.1% | -51.4% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.55 | 1.31 | 0.00 | 0.00 | 0.25 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -4.4M | -41M | -55M | -67M | -61M | -60M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | -31.3% | -102.6% | -187.0% | -80.1% | -41.1% | -51.4% |
| Shares Outstanding | 12M | 12M | 7M | 5M | 56M | 36M |
SYNLOGIC, INC. passes 0 of 9 quality checks, indicating weak fundamentals.
SYNLOGIC, INC. (SYBX) has a 5-year average return on invested capital (ROIC) of -76.4%. This is below average and may indicate limited pricing power.
SYNLOGIC, INC. (SYBX) has a market capitalization of $7M. It is classified as a small-cap stock.
SYNLOGIC, INC. (SYBX) does not currently pay a regular dividend.
SYNLOGIC, INC. (SYBX) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
SYNLOGIC, INC. (SYBX) generated $-32 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
SYNLOGIC, INC. (SYBX) has a debt-to-equity ratio of 0.55. This indicates moderate leverage.
SYNLOGIC, INC. (SYBX) reported earnings per share (EPS) of $-1.92 in its most recent fiscal year.
SYNLOGIC, INC. (SYBX) has a return on equity (ROE) of -102.6%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 9 years of financial data for SYNLOGIC, INC. (SYBX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
SYNLOGIC, INC. (SYBX) has a book value per share of $1.05, based on its most recent annual SEC filing.